PL2192893T3 - Kompozycja przeciwgrzybicza - Google Patents

Kompozycja przeciwgrzybicza

Info

Publication number: PL2192893T3
Authority: PL; Poland
Prior art keywords: antifungal composition; antifungal; composition
Prior art date: 2007-08-21

Application number

PL08787353T

Other languages

English (en)

Inventor

Christian Bucher

Günter Ditzinger

Estelle Dubois

Delphine Marchaud

Original Assignee

Basilea Pharmaceutica Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2007-08-21

Filing date

2008-08-20

Publication date

2015-12-31

2008-08-20 Application filed by Basilea Pharmaceutica Ag filed Critical Basilea Pharmaceutica Ag

2015-12-31 Publication of PL2192893T3 publication Critical patent/PL2192893T3/pl

Links

239000012871 anti-fungal composition Substances 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Dispersion Chemistry (AREA)
Epidemiology (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

PL08787353T 2007-08-21 2008-08-20 Kompozycja przeciwgrzybicza PL2192893T3 (pl)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
EP07114652		2007-08-21
PCT/EP2008/060905 WO2009024590A2 (en)	2007-08-21	2008-08-20	Antifungal composition
EP08787353.5A EP2192893B1 (en)	2007-08-21	2008-08-20	Antifungal composition

Publications (1)

Publication Number	Publication Date
PL2192893T3 true PL2192893T3 (pl)	2015-12-31

Family

ID=38656753

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL08787353T PL2192893T3 (pl)	2007-08-21	2008-08-20	Kompozycja przeciwgrzybicza

Country Status (14)

Country	Link
US (1)	US8536208B2 (pl)
EP (1)	EP2192893B1 (pl)
JP (1)	JP5576279B2 (pl)
KR (1)	KR101493546B1 (pl)
CN (1)	CN101784259B (pl)
AU (1)	AU2008290536B2 (pl)
BR (1)	BRPI0815595B8 (pl)
CA (1)	CA2697328C (pl)
ES (1)	ES2551125T3 (pl)
MX (1)	MX2010001730A (pl)
PL (1)	PL2192893T3 (pl)
PT (1)	PT2192893E (pl)
WO (1)	WO2009024590A2 (pl)
ZA (1)	ZA201000925B (pl)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
MX340815B (es) *	2011-12-02	2016-07-27	Colgate Palmolive Co	Composicion de cuidado bucal que comprende isobutil magnolol.
CA3028927C (en) *	2016-06-20	2024-01-09	Capretto Ehf.	Thermostable formulation of biologically active substances
CN105943500B (zh) *	2016-07-08	2019-01-04	河南省立眼科医院	一种含有艾沙康唑的眼用纳米胶束抗真菌溶液
WO2018219804A1 (en) *	2017-06-02	2018-12-06	Bayer Pharma Aktiengesellschaft	Self-microemulsifying drug delivery systems
GB201813229D0 (en) *	2018-08-14	2018-09-26	Ocutec Ltd	Formulation
KR20250008895A (ko) *	2022-05-12	2025-01-16	주식회사 지뉴브	안정한 액상 제약 제제
TW202541814A (zh)	2023-11-30	2025-11-01	瑞士商巴塞利亞阿爾斯維爾藥業國際股份有限公司	用於治療真菌感染的藥物組合

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6054136A (en)	1993-09-30	2000-04-25	Gattefosse S.A.	Orally administrable composition capable of providing enhanced bioavailability when ingested
NZ270418A (en)	1994-02-07	1997-09-22	Eisai Co Ltd	Polycyclic triazole & imidazole derivatives, antifungal compositions
AU2931399A (en)	1998-03-06	1999-09-20	F. Hoffmann-La Roche Ag	3-(4-(4-cyanophenyl)thiazol-2-y))-1-(1h-1,2,4-triazol-1-yl) -butan-2-ol derivatives having antifungal activity
WO1999056727A2 (en) *	1998-05-07	1999-11-11	Elan Corporation, Plc	Solvent/cosolvent free microemulsion and emulsion preconcentrate drug delivery systems
CA2388320C (en)	1999-11-02	2009-12-15	Basilea Pharmaceutica Ag	N-substituted carbamoyloxyalkyl-azolium derivatives
JP2001302544A (ja) *	1999-12-10	2001-10-31	Takeda Chem Ind Ltd	経口用医薬組成物
US20030072807A1 (en) *	2000-12-22	2003-04-17	Wong Joseph Chung-Tak	Solid particulate antifungal compositions for pharmaceutical use
FR2827770B1 (fr)	2001-07-27	2005-08-19	Gattefosse Ets Sa	Composition pharmaceutique a usage oral comprenant un principe actif susceptible de subir un important effet de premier passage intestinal
US20050186142A1 (en) *	2002-10-25	2005-08-25	Foamix Ltd.	Kit and composition of imidazole with enhanced bioavailability
EP1498123A1 (en) *	2003-07-18	2005-01-19	Aventis Pharma S.A.	Emulsifying systems containing azetidine derivatives
FR2861992B1 (fr) *	2003-11-10	2007-07-20	Sanofi Synthelabo	Composition pharmaceutique destinee a l'administration orale d'un derive de pyrazole-3-carboxamide.
EP1715847A1 (en) *	2003-12-23	2006-11-02	Tibotec Pharmaceuticals Ltd.	Self-microemulsifying drug delivery systems of a hiv protease inhibitor6
FR2873585B1 (fr) *	2004-07-27	2006-11-17	Aventis Pharma Sa	Nouvelles formulations galeniques de principes actifs
MX2007006183A (es) *	2004-11-24	2007-09-11	Merck & Co Inc	Formulaciones farmaceuticas liquidas y semisolidas para administracion oral de una amida sustituida.
WO2007038796A1 (en) *	2005-09-29	2007-04-05	Repros Therapeutics Inc.	Formulations with improved bioavailability, comprising a steroid derivative and a polyglycolysed glyceride
CA2618705C (en) *	2005-11-07	2014-04-22	Murty Pharmaceuticals, Inc.	Improved delivery of tetrahydrocannabinol

2008
- 2008-08-20 MX MX2010001730A patent/MX2010001730A/es active IP Right Grant
- 2008-08-20 BR BRPI0815595A patent/BRPI0815595B8/pt active IP Right Grant
- 2008-08-20 ES ES08787353.5T patent/ES2551125T3/es active Active
- 2008-08-20 CN CN2008801036395A patent/CN101784259B/zh active Active
- 2008-08-20 WO PCT/EP2008/060905 patent/WO2009024590A2/en not_active Ceased
- 2008-08-20 AU AU2008290536A patent/AU2008290536B2/en not_active Ceased
- 2008-08-20 JP JP2010521419A patent/JP5576279B2/ja active Active
- 2008-08-20 EP EP08787353.5A patent/EP2192893B1/en active Active
- 2008-08-20 US US12/674,048 patent/US8536208B2/en active Active
- 2008-08-20 KR KR20107006169A patent/KR101493546B1/ko not_active Expired - Fee Related
- 2008-08-20 PL PL08787353T patent/PL2192893T3/pl unknown
- 2008-08-20 CA CA2697328A patent/CA2697328C/en active Active
- 2008-08-20 PT PT87873535T patent/PT2192893E/pt unknown
2010
- 2010-02-08 ZA ZA201000925A patent/ZA201000925B/xx unknown

Also Published As

Publication number	Publication date
BRPI0815595B8 (pt)	2021-05-25
CA2697328A1 (en)	2009-02-26
BRPI0815595A8 (pt)	2018-06-19
HK1141742A1 (en)	2010-11-19
US8536208B2 (en)	2013-09-17
CN101784259A (zh)	2010-07-21
KR101493546B1 (ko)	2015-02-16
MX2010001730A (es)	2010-03-10
PT2192893E (pt)	2015-11-09
US20110281918A1 (en)	2011-11-17
BRPI0815595B1 (pt)	2021-02-09
JP5576279B2 (ja)	2014-08-20
WO2009024590A2 (en)	2009-02-26
AU2008290536B2 (en)	2012-02-09
WO2009024590A3 (en)	2009-06-04
EP2192893B1 (en)	2015-08-19
CA2697328C (en)	2015-08-11
ES2551125T3 (es)	2015-11-16
BRPI0815595A2 (pt)	2015-03-03
ZA201000925B (en)	2010-10-27
JP2010536826A (ja)	2010-12-02
AU2008290536A1 (en)	2009-02-26
EP2192893A2 (en)	2010-06-09
CN101784259B (zh)	2013-03-27
KR20100064370A (ko)	2010-06-14

Publication	Publication Date	Title
GB0718777D0 (en)	2007-11-07	Composition
GB0700534D0 (en)	2007-02-21	Composition
PL2191828T3 (pl)	2017-02-28	Przeciwgrzybicza kompozycja farmaceutyczna
EP2206430A4 (en)	2012-08-22	ANTIMYCOTIC COMPOSITION
GB0717182D0 (en)	2007-10-17	Composition
GB0722550D0 (en)	2007-12-27	Composition
GB0714575D0 (en)	2007-09-05	Composition
GB0710888D0 (en)	2007-07-18	Composition
ZA201000925B (en)	2010-10-27	Antifungal composition
GB0716591D0 (en)	2007-10-03	Composition
GB0714569D0 (en)	2007-09-05	Composition
GB0705885D0 (en)	2007-05-02	Composition
GB0703719D0 (en)	2007-04-04	Composition
GB0706343D0 (en)	2007-05-09	Composition
GB0702446D0 (en)	2007-03-21	Composition
GB0707972D0 (en)	2007-05-30	Composition
GB0706739D0 (en)	2007-05-16	Composition
GB0704651D0 (en)	2007-04-18	Composition
GB0723825D0 (en)	2008-01-23	Composition
GB0704659D0 (en)	2007-04-18	Composition
GB0721430D0 (en)	2007-12-12	Composition
GB0713976D0 (en)	2007-08-29	Composition
GB0710559D0 (en)	2007-07-11	Composition
GB0703087D0 (en)	2007-03-28	Composition
GB0604934D0 (en)	2006-04-19	Antifungal compositions